Biomarkers Predicting Recurrence and Progression of Ductal Carcinoma In Situ Treated by Lumpectomy Alone

被引：8
|
作者：
Allred, D. Craig [1 ]
机构：
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
来源：
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2010年 / 102卷 / 09期
关键词：
SURGICAL ADJUVANT BREAST; INTRADUCTAL-CARCINOMA; PATHOLOGICAL FINDINGS; PROTOCOL B-17; CANCER; TAMOXIFEN; EXPRESSION; PHENOTYPE; DCIS; B-24;
D O I：
10.1093/jnci/djq118
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：585 / 587
页数：3
相关论文
共 50 条
  • [41] Is loss of p53 a driver of ductal carcinoma in situ progression?
    Morrissey, Rhiannon L.
    Thompson, Alastair M.
    Lozano, Guillermina
    BRITISH JOURNAL OF CANCER, 2022, 127 (10) : 1744 - 1754
  • [42] Clinical risk score to predict likelihood of recurrence after ductal carcinoma in situ treated with breast-conserving surgery
    Punglia, Rinaa S.
    Jiang, Wei
    Lipsitz, Stuart R.
    Hughes, Melissa E.
    Schnitt, Stuart J.
    Hassett, Michael J.
    Nekhlyudov, Larissa
    Achacoso, Ninah
    Edge, Stephen
    Javid, Sara H.
    Niland, Joyce C.
    Theriault, Richard L.
    Wong, Yu-Ning
    Habel, Laurel A.
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (03) : 751 - 759
  • [43] Predictors of disease progression in ductal carcinoma in situ of the breast and vascular patterns
    Adler, Esther H.
    Sunkara, Jaya L.
    Patchefsky, Arthur S.
    Koss, Leopold G.
    Oktay, Maja H.
    HUMAN PATHOLOGY, 2012, 43 (04) : 550 - 556
  • [44] Genomic landscape of ductal carcinoma in situ and association with progression
    Lin, Chieh-Yu
    Vennam, Sujay
    Purington, Natasha
    Lin, Eric
    Varma, Sushama
    Han, Summer
    Desa, Manisha
    Seto, Tina
    Wang, Nicholas J.
    Stehr, Henning
    Troxell, Megan L.
    Kurian, Allison W.
    West, Robert B.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 178 (02) : 307 - 316
  • [45] Progression of Ductal Carcinoma in Situ from the Pathological Perspective
    Cunha, Pedro Oscar R.
    Ornstein, Mark
    Jones, J. Louise
    BREAST CARE, 2010, 5 (04) : 233 - 239
  • [46] Nomogram for Predicting the Risk of Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ
    Rudloff, Udo
    Jacks, Lindsay M.
    Goldberg, Jessica I.
    Wynveen, Christine A.
    Brogi, Edi
    Patil, Sujata
    Van Zee, Kimberly J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (23) : 3762 - 3769
  • [47] Ki-67 Expression as a Factor Predicting Recurrence of Ductal Carcinoma In Situ of the Breast: A Systematic Review and Meta-Analysis
    Poulakaki, Nikiforita
    Makris, Georgios-Marios
    Papanota, Aristea-Maria
    Marineli, Filio
    Marinelis, Alexandros
    Battista, Marco-Johannes
    Boehm, Daniel
    Psyrri, Amanda
    Sergentanis, Theodoros N.
    CLINICAL BREAST CANCER, 2018, 18 (02) : 157 - +
  • [48] Impact of Margin Status on Local Recurrence After Mastectomy for Ductal Carcinoma In Situ
    Childs, Stephanie K.
    Chen, Yu-Hui
    Duggan, Margaret M.
    Golshan, Mehra
    Pochebit, Stephen
    Punglia, Rinaa S.
    Wong, Julia S.
    Bellon, Jennifer R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (04): : 948 - 952
  • [49] Clinicopathological Characteristics and Factors Affecting Recurrence of Ductal Carcinoma In Situ in Korean Women
    Kim, Ji Sun
    Moon, Hyeong-Gon
    Ahn, Soo Kyung
    Min, Jun Won
    Shin, Hee Chul
    Kim, Han Suk
    Yeom, Cha Kyung
    Ha, Sung Hwan
    Chie, Eui Kyu
    Han, Wonshik
    Noh, Dong Young
    JOURNAL OF BREAST CANCER, 2010, 13 (04) : 392 - 397
  • [50] Aurora Kinase A Is an Independent Predictor of Invasive Recurrence in Breast Ductal Carcinoma in situ
    Miligy, Islam M.
    Toss, Michael S.
    Gorringe, Kylie L.
    Ellis, Ian O.
    Green, Andrew R.
    Rakha, Emad A.
    PATHOBIOLOGY, 2022, 89 (06) : 382 - 392
12345